<html>
<head>
<style><!--
.hmmessage P
{
margin:0px;
padding:0px
}
body.hmmessage
{
font-size: 12pt;
font-family:Calibri
}
--></style></head>
<body class='hmmessage'><div dir='ltr'>From: yadonzai@paho.org<br><div>To: jayusp@hotmail.com<br>Date: Tue, 4 Jun 2013 10:53:09 -0300<br>Subject: RE: LEISHMANIASES QUESTIONNAIRE-QUESTIONARIO-CUESTIONARIO<br><style><!--
.ExternalClass p.ecxMsoNormal, .ExternalClass li.ecxMsoNormal, .ExternalClass div.ecxMsoNormal {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass a:link, .ExternalClass span.ecxMsoHyperlink {
color:blue;
text-decoration:underline;
}
.ExternalClass span.ecxMsoHyperlinkFollowed {
color:purple;
text-decoration:underline;
}
.ExternalClass p {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass p.ecxMsoAcetate, .ExternalClass li.ecxMsoAcetate, .ExternalClass div.ecxMsoAcetate {
font-size:8.0pt;
font-family:"Tahoma","sans-serif";
}
.ExternalClass p.ecxmsonormal, .ExternalClass li.ecxmsonormal, .ExternalClass div.ecxmsonormal {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass p.ecxmsoplaintext, .ExternalClass li.ecxmsoplaintext, .ExternalClass div.ecxmsoplaintext {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass p.ecxmsoacetate, .ExternalClass li.ecxmsoacetate, .ExternalClass div.ecxmsoacetate {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass p.ecxmsochpdefault, .ExternalClass li.ecxmsochpdefault, .ExternalClass div.ecxmsochpdefault {
font-size:12.0pt;
font-family:"Times New Roman","serif";
}
.ExternalClass span.ecxmsohyperlink {
}
.ExternalClass span.ecxmsohyperlinkfollowed {
}
.ExternalClass span.ecxplaintextchar {
}
.ExternalClass span.ecxballoontextchar {
}
.ExternalClass span.ecxestilodeemail17 {
}
.ExternalClass span.ecxtextodebalochar {
}
.ExternalClass span.ecxtextosemformataochar {
}
.ExternalClass span.ecxemailstyle26 {
}
.ExternalClass span.ecxemailstyle27 {
}
.ExternalClass p.ecxmsonormal1, .ExternalClass li.ecxmsonormal1, .ExternalClass div.ecxmsonormal1 {
font-size:11.0pt;
font-family:"Calibri","sans-serif";
}
.ExternalClass span.ecxmsohyperlink1 {
color:blue;
text-decoration:underline;
}
.ExternalClass span.ecxmsohyperlinkfollowed1 {
color:purple;
text-decoration:underline;
}
.ExternalClass p.ecxmsoplaintext1, .ExternalClass li.ecxmsoplaintext1, .ExternalClass div.ecxmsoplaintext1 {
font-size:11.0pt;
font-family:"Calibri","sans-serif";
}
.ExternalClass p.ecxmsoacetate1, .ExternalClass li.ecxmsoacetate1, .ExternalClass div.ecxmsoacetate1 {
font-size:8.0pt;
font-family:"Tahoma","sans-serif";
}
.ExternalClass span.ecxplaintextchar1 {
font-family:Consolas;
}
.ExternalClass span.ecxballoontextchar1 {
font-family:"Tahoma","sans-serif";
}
.ExternalClass p.ecxmsochpdefault1, .ExternalClass li.ecxmsochpdefault1, .ExternalClass div.ecxmsochpdefault1 {
font-size:12.0pt;
font-family:"Calibri","sans-serif";
}
.ExternalClass span.ecxestilodeemail171 {
font-family:"Calibri","sans-serif";
color:#1F497D;
}
.ExternalClass span.ecxtextodebalochar1 {
font-family:"Tahoma","sans-serif";
}
.ExternalClass span.ecxtextosemformataochar1 {
font-family:"Calibri","sans-serif";
}
.ExternalClass span.ecxemailstyle261 {
font-family:"Calibri","sans-serif";
color:#1F497D;
}
.ExternalClass span.ecxemailstyle271 {
font-family:"Calibri","sans-serif";
color:#1F497D;
}
.ExternalClass span.ecxBalloonTextChar {
font-family:"Tahoma","sans-serif";
}
.ExternalClass span.ecxEmailStyle46 {
font-family:"Calibri","sans-serif";
color:#1F497D;
}
.ExternalClass .ecxMsoChpDefault {
font-size:10.0pt;
}
.ExternalClass div.ecxWordSection1 {
}
--></style><div class="ecxWordSection1"><p class="ecxMsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D;"> </span></p><p class="ecxMsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D;background:yellow;">ENGLISH</span><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D;"></span></p><div><div><div><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;">Dear Colleagues</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">I am writing to you to ask for your invaluable answers to a survey that the Pan American Health Organization (PAHO) has developed to define research priorities for leishmaniasis. Following on from the success of Worldleish5, PAHO requested to the conference´s organizing committee the email addresses of all participants. In addition, the questionnaire is circulated to participants of the Leish-L network. Apologies for any cross-posting.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">The survey aims to identify:</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">I. Successes in the last 5 years relating to leishmaniasis research and development.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">II. Progress on research topics.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">III. Elicitation of criteria for future research prioritization.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><b><u><span style="font-size:14.0pt;font-family:"Calibri","sans-serif";color:#1F497D;">We kindly ask you to return the questionnaire by June 30<sup>th</sup>.</span></u></b><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">You will be able to complete the questionnaire <b>online and off-line</b> (on the PDF file attached to this email), and submit your responses on-line by just clicking on the "SUBMIT" button at the end of the questionnaire.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><b><span style="font-family:"Calibri","sans-serif";color:#1F497D;">ENGLISH</span></b><span style="font-family:"Calibri","sans-serif";color:#1F497D;"> - <a href="https://adobeformscentral.com/?f=Y%2aQSP77XdRU-KSSoOgUHdg" target="_blank">https://adobeformscentral.com/?f=Y%2AQSP77XdRU-KSSoOgUHdg</a> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">In case of doubt or question please do not hesitate to contact Dr Zaida Yadon (PAHO), email address: </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR"><a href="mailto:yadonzai@paho.org"><span lang="EN-US">yadonzai@paho.org</span></a></span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;">Thank you very much for your collaboration.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;background:yellow;" lang="PT-BR">PORTUGUES</span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">:</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">Caros Colegas,<br><br>Escrevo para lhes pedir suas inestimáveis respostas para a pesquisa que a Organização Pan-Americana da Saúde (OPAS) desenvolveu para definir prioridades de pesquisa para leishmanioses. Na sequência do sucesso de Worldleish5, a OPAS solicitou à comissão organizadora da conferência os endereços de email de todos os participantes. Além disso, o questionário é distribuído aos participantes da rede <a href="mailto:leish-l-bounces@lineu.icb.usp.br"><span style="color:#1F497D;text-decoration:none;">leish-l</span></a>. Pedimos desculpas por qualquer postagem cruzada.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">A pesquisa tem como objetivo identificar:<br>I. Sucessos nos últimos cinco anos em matéria de investigação e desenvolvimento da leishmaniose.<br>II. Progresso em temas de investigação.<br>III. Identificação de critérios para a priorização.<br><br></span><b><u><span style="font-size:14.0pt;font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">Pedimos-lhe gentilmente devolver o questionário até o dia 30 de junho.</span></u></b><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><b><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">PORTUGUÊS</span></b><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR"> - <a href="https://adobeformscentral.com/?f=REWULfUZI6wQCQjF9s4LVA" target="_blank">https://adobeformscentral.com/?f=REWULfUZI6wQCQjF9s4LVA</a> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">Você será capaz de preencher o questionário <b>on-line e off-line</b> (em arquivo PDF anexado a este e-mail), e enviar suas respostas on-line apenas clicando no botão "ENVIAR" no final do questionário.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR">Em caso de dúvida ou pergunta, por favor, não hesite em contatar a Dra Zaida Yadon (OPAS), e-mail: <a href="mailto:yadonzai@paho.org">yadonzai@paho.org</a><br><br>Muito obrigado pela sua colaboração.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;" lang="PT-BR"> </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;background:yellow;" lang="ES">ESPAÑOL:</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">Estimados Colegas,</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"><br>Les escribo para pedirles sus respuestas a la encuesta que la Organización Panamericana de la Salud (OPS) ha desarrollado para definir las prioridades de investigación para la leishmaniosis. Tras el éxito de Worldleish5, la OPS pidió al comité organizador de la conferencia las direcciones de correo electrónico de todos los participantes. Además, el cuestionario se distribuye a los participantes de la red </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR"><a href="mailto:leish-l-bounces@lineu.icb.usp.br"><span style="color:#1F497D;text-decoration:none;" lang="ES">leish-l</span></a></span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"> Nos disculpamos por cualquier envío cruzado.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"><br>La encuesta tiene como objetivo identificar:<br>I. Los éxitos, en los últimos cinco años, en la investigación y el desarrollo relacionado a las leishmaniosis</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">II. Los avances en los temas de investigación.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">III. Identificación de los criterios para la priorización.<br><br></span><b><u><span style="font-size:14.0pt;font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">Le pedimos gentilmente que envíe el cuestionario hasta el 30 de junio.</span></u></b><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">Usted podrá completar el cuestionario <b>online</b> y <b>offline</b> (en el archivo PDF adjunto a este correo electrónico), y enviar sus respuestas en online con sólo hacer clic en el botón "ENVIAR" al final del cuestionario.<br><br>ESPAÑOL - </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR"><a href="https://adobeformscentral.com/?f=wC1kiPOu2IpNlXjgavocjw" target="_blank"><span lang="ES">https://adobeformscentral.com/?f=wC1kiPOu2IpNlXjgavocjw</span></a> </span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"><br></span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES-MX">En</span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"> caso de </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES-MX">dudas </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES">o pregunta, no </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES-MX">dude en ponerse</span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"> en </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES-MX">contacto con la</span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"> Dra. Zaida Yadon (OPS), el correo electrónico: </span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="PT-BR"><a href="mailto:yadonzai@paho.org"><span lang="ES">yadonzai@paho.org</span></a></span><span style="font-family:"Calibri","sans-serif";color:#1F497D;" lang="ES"> <br><br>Gracias por su colaboración.</span><span style="font-family:"Calibri","sans-serif";"></span></p><p class="ecxMsoNormal"><span style="font-family:"Calibri","sans-serif";color:black;"> </span><span style="font-family:"Calibri","sans-serif";"></span></p></div></div></div></div></div> </div></body>
</html>